WORLD
China CanSinoBIO's Vaccine 57.5% Effective Against COVID in Phase III Trial-study - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'China CanSinoBIO's vaccine 57.5% effective against COVID in Phase III trial-study ...'
China CanSinoBIO's vaccine 57.5% effective against COVID in Phase III trial-study https://t.co/SuneneZbzA pic.twitter.com/3RskNMZKpN— Reuters (@Reuters) December 24, 2021
(The above story first appeared on LatestLY on Dec 24, 2021 10:36 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
